Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TRIFLURIDINE USP, with a corresponding US DMF Number 33880.
Remarkably, this DMF maintains an Active status since its submission on May 23, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 05, 2019, and payment made on May 23, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II